Most of these visits (69.3%) were due to severe gastrointestinal adverse reactions
Seek emergency room or urgent care services if you encounter: Intense vomiting and diarrhea Dehydration indicators including lightheadedness, excessive thirst, reduced urination frequency, or concentrated urine Sudden onset of substantial abdominal pain Blood present in your bowel movements or vomit Conclusion GLP-1 medications offer valuable benefits for managing type 2 diabetes and achieving weight loss, but understanding their potential impact on digestive health is essential for safe and effective treatment
Qin et al., 2015
Broad Therapeutic Effects : Tirzepatide results in clinically significant improvements in multiple obesity-related complications, including sleep apnea, metabolic dysfunction-associated steatohepatitis, heart failure with preserved ejection fraction, and diabetes prevention [79]
Biopharma companies with GLP-1 (glucagon-like peptide-1) analogs, which have become a new trend in the obesity treatment market long dominated by appetite suppressants and fat-absorbance inhibitors, are upgrading their treatments